{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:20:17Z","timestamp":1707524417043},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,10,1]]},"DOI":"10.7759\/cureus.18429","type":"journal-article","created":{"date-parts":[[2021,10,2]],"date-time":"2021-10-02T01:29:50Z","timestamp":1633138190000},"source":"Crossref","is-referenced-by-count":0,"title":["Unique Presentation of Idiopathic Retroperitoneal Fibrosis in a Primary Care Setting"],"prefix":"10.7759","author":[{"given":"Salam","family":"Khalil","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nerosanth","family":"Selvarajah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satish","family":"Solanki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Holli","family":"Neiman-Hart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glenn","family":"Dregansky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2015101110","article-title":"Idiopathic retroperitoneal fibrosis","volume":"27","author":"Vaglio A","year":"2016","unstructured":"Vaglio A, Maritati F. Idiopathic retroperitoneal fibrosis. J Am Soc Nephrol. 2016, 27:1880-9. 10.1681\/ASN.2015101110","journal-title":"J Am Soc Nephrol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)68035-5","article-title":"Retroperitoneal fibrosis","volume":"367","author":"Vaglio A","year":"2006","unstructured":"Vaglio A, Salvarani C, Buzio C. Retroperitoneal fibrosis. Lancet. 2006, 367:241-51. 10.1016\/S0140-6736(06)68035-5","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.revmed.2014.10.008","article-title":"Idiopathic and secondary forms of retroperitoneal fibrosis: a diagnostic approach","volume":"36","author":"Urban ML","year":"2015","unstructured":"Urban ML, Palmisano A, Nicastro M, Corradi D, Buzio C, Vaglio A. Idiopathic and secondary forms of retroperitoneal fibrosis: a diagnostic approach. Rev Med Interne. 2015, 36:15-21. 10.1016\/j.revmed.2014.10.008","journal-title":"Rev Med Interne"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2009.04.019","article-title":"Idiopathic retroperitoneal fibrosis: a review of the pathogenesis and approaches to treatment","volume":"54","author":"Swartz RD","year":"2009","unstructured":"Swartz RD. Idiopathic retroperitoneal fibrosis: a review of the pathogenesis and approaches to treatment. Am J Kidney Dis. 2009, 54:546-53. 10.1053\/j.ajkd.2009.04.019","journal-title":"Am J Kidney Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2006.03.011","article-title":"Autoimmune aspects of chronic periaortitis","volume":"5","author":"Vaglio A","year":"2006","unstructured":"Vaglio A, Greco P, Corradi D, Palmisano A, Martorana D, Ronda N, Buzio C. Autoimmune aspects of chronic periaortitis. Autoimmun Rev. 2006, 5:458-64. 10.1016\/j.autrev.2006.03.011","journal-title":"Autoimmun Rev"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2019.04.020","article-title":"Idiopathic retroperitoneal fibrosis: long-term risk and predictors of relapse","volume":"74","author":"Raffiotta F","year":"2019","unstructured":"Raffiotta F, da Silva Escoli R, Quaglini S, et al.. Idiopathic retroperitoneal fibrosis: long-term risk and predictors of relapse. Am J Kidney Dis. 2019, 74:742-50. 10.1053\/j.ajkd.2019.04.020","journal-title":"Am J Kidney Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1148\/rg.332125085","article-title":"Retroperitoneal fibrosis: role of imaging in diagnosis and follow-up","volume":"33","author":"Caiafa RO","year":"2013","unstructured":"Caiafa RO, Vinuesa AS, Izquierdo RS, Brufau BP, Ayuso Colella JR, Molina CN. Retroperitoneal fibrosis: role of imaging in diagnosis and follow-up. Radiographics. 2013, 33:535-52. 10.1148\/rg.332125085","journal-title":"Radiographics"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2298\/vsp0706385o","article-title":"[Mycophenolate mofetil combined with steroids: new experiences in the treatment of idiopathic retroperitoneal fibrosis]","volume":"64","author":"Obrencevi\u0107 K","year":"2007","unstructured":"Obrencevi\u0107 K, Jovanovi\u0107 D, Kovacevi\u0107 Z, Hrvacevi\u0107 R, Ignjatovi\u0107 L, Mijuskovi\u0107 M. [Mycophenolate mofetil combined with steroids: new experiences in the treatment of idiopathic retroperitoneal fibrosis]. Vojnosanit Pregl. 2007, 64:385-90. 10.2298\/vsp0706385o","journal-title":"Vojnosanit Pregl"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.5414\/cnp69260","article-title":"Idiopathic retroperitoneal fibrosis: a role for mycophenolate mofetil","volume":"69","author":"Swartz RD","year":"2008","unstructured":"Swartz RD, Lake AM, Roberts WW, Faerber GJ, Wolf JS Jr. Idiopathic retroperitoneal fibrosis: a role for mycophenolate mofetil. Clin Nephrol. 2008, 69:260-8. 10.5414\/cnp69260","journal-title":"Clin Nephrol"},{"key":"ref10","doi-asserted-by":"crossref","DOI":"10.1016\/S0022-5347(05)64677-0","article-title":"Steroid therapy for idiopathic retroperitoneal fibrosis: dose and duration","volume":"168","author":"Kardar AH","year":"2002","unstructured":"Kardar AH, Kattan S, Lindstedt E, Hanash K. Steroid therapy for idiopathic retroperitoneal fibrosis: dose and duration. J Urol. 2002, 168:550-5.","journal-title":"J Urol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.13040\/IJPSR.0975-8232.8(9).3991-99","article-title":"The risk of hyperglycemia associated with the use of prescribed medications","volume":"8","author":"Abdel-Razaq W","year":"2017","unstructured":"Abdel-Razaq W, Ismail W, Al Anazi A, Alissa AR. The risk of hyperglycemia associated with the use of prescribed medications. Int J Pharm Sci Res. 2017, 8:3991-9. 10.13040\/IJPSR.0975-8232.8(9).3991-99","journal-title":"Int J Pharm Sci Res"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ando.2008.09.007","article-title":"Type 1 diabetes and idiopathic retroperitoneal fibrosis: case report","volume":"70","author":"Sum S","year":"2009","unstructured":"Sum S, Moreau F, Jacquemin D, et al.. Type 1 diabetes and idiopathic retroperitoneal fibrosis: case report. Ann Endocrinol (Paris). 2009, 70:129-32. 10.1016\/j.ando.2008.09.007","journal-title":"Ann Endocrinol (Paris)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfaa083","article-title":"Idiopathic retroperitoneal fibrosis: an update for nephrologists","volume":"36","author":"Raglianti V","year":"2021","unstructured":"Raglianti V, Rossi GM, Vaglio A. Idiopathic retroperitoneal fibrosis: an update for nephrologists. Nephrol Dial Transplant. 2021, 36:1773-81. 10.1093\/ndt\/gfaa083","journal-title":"Nephrol Dial Transplant"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/67280-unique-presentation-of-idiopathic-retroperitoneal-fibrosis-in-a-primary-care-setting","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:31:01Z","timestamp":1707507061000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/67280-unique-presentation-of-idiopathic-retroperitoneal-fibrosis-in-a-primary-care-setting"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,1]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.18429","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10,1]]}}}